Publication Year

Connor, K., M. Harris, M. Edwards, A. Chu, G. Clark, and B. Finley. 2004. Estimating the total TEQ in human blood from naturally-occurring vs. anthropogenic dioxins: A dietary study.  Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Haws, L. Roundtable: Is it Time to Reevaluate the Toxic Equivalency Factors for PCDDs, PCDFs, and Dioxin-Like PCBs? The Use of Toxicity Equivalence Factors (TEFs) for PCDDs, PCDFs, and Dioxin-Like PCBs in Risk Assessment: Improving the Process. Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Proctor DM, Panko JP, Liebig EW, Paustenbach, DJ. 2004. Estimating historical occupational exposure to airborne hexavalent chromium in a chromate production plant: 1940–1972. Occup Environ Hyg. 1:752–767.

Schecter, A, Papke O, Tung KC, Staskal DF, and Birnbaum L. 2004. Polybrominated diphenyl ether contamination of United States food. Environ Sci Technol 38(20):5306-5311.

Haws, L., M. Harris, S. Su, L. Birnbaum, M. DeVito, W. Farland, N. Walker, K. Connor, A.Santamaria, and B. Finley. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Date RF, Walden GL, McMillan DA, Barker ML, Gerlach RW. Comparative peroxide degradation with brush-applied whitening systems. J Dent Res 83 (Abstract 1471), 2004.

Walden GL, McMillan DA, Sagel PA, Barker ML, Gerlach RW. Kinetics of 10% hydrogen peroxide whitening strips. J Dent Res 83 (Abstract 3812), 2004.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, and Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554.

Haws, L., M. Harris, S. Su, N. Walker, L. Birnbaum, M. DeVito, W. Farland, K. Connor, A. Santamaria, and B. Finley. A preliminary approach to characterizing variability and uncertainty in the mammalian PCDD/F and PCB TEFs. Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Gerlach RW, Barker ML, McMillan DA, Sagel PA, Walden GL. 2004. In-use comparative kinetics of professional whitening strips: Peroxide recovery from strips, teeth, gingiva and saliva. Comp Cont Educ Dent 25(Suppl. 2):14–20.

Warren DA, Kerger BD, Britt JK andJames RC. 2004. Development of an oral cancer slope factor for Aroclor 1268. Regul Toxicol Pharmacol 40:42-53.

Perry, C.S. and Morton, E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis’ Annual Meeting. December 5-8, 2004. Palm Springs, CA.

Panko JM, Unice KM, Shay EC, Price P. 2004. Childhood exposure assessment of acetone. International Society for Exposure Assessment 2004.

Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67:43–71.

Staskal, D.F., J.J. Diliberto, M.J. DeVito, and L.S. Birnbaum. 2004. Tissue distribution and elimination of BDE 47 in mice following a single oral dose.  Dioxin 2004. September 6-10, 2004. Berlin, Germany.

Rogers JM, Brannen KC, Barbee BD, Zucker RM, Degitz SJ. 2004. Maternal methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis and cervical vertebral malformations in C57BL/6J mice. Birth Defects Res, Part B, Dev Reprod Toxicol 71:17–25.